| 000 | 01573 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250512091920.0 | ||
| 264 | 0 | _c19730924 | |
| 008 | 197309s 0 0 eng d | ||
| 022 | _a0012-1797 | ||
| 024 | 7 |
_a10.2337/diab.22.7.552 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPosner, B I | |
| 245 | 0 | 0 |
_aInsulin metabolizing enzyme activities in human placental tissue. _h[electronic resource] |
| 260 |
_bDiabetes _cJul 1973 |
||
| 300 |
_a552-63 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdrenocorticotropic Hormone _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDialysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucagon _xpharmacology |
| 650 | 0 | 4 |
_aGlutathione _xmetabolism |
| 650 | 0 | 4 |
_aGrowth Hormone _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 |
_aInsulin _xmetabolism |
| 650 | 0 | 4 |
_aMuscles _xenzymology |
| 650 | 0 | 4 |
_aNADP _xmetabolism |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 |
_aOxytocin _xpharmacology |
| 650 | 0 | 4 |
_aPeptide Hydrolases _xmetabolism |
| 650 | 0 | 4 |
_aPlacenta _xdrug effects |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPregnancy in Diabetics _xmetabolism |
| 650 | 0 | 4 |
_aProinsulin _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aSerum Albumin _xpharmacology |
| 650 | 0 | 4 |
_aSerum Albumin, Bovine _xpharmacology |
| 650 | 0 | 4 |
_aSulfhydryl Compounds _xmetabolism |
| 650 | 0 | 4 |
_aVasopressins _xpharmacology |
| 773 | 0 |
_tDiabetes _gvol. 22 _gno. 7 _gp. 552-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2337/diab.22.7.552 _zAvailable from publisher's website |
| 999 |
_c4151799 _d4151799 |
||